HIV-1 Reverse Transcriptase Structure with RNase H Inhibitor Dihydroxy Benzoyl Naphthyl Hydrazone Bound at a Novel Site

The rapid emergence of drug-resistant variants of human immunodeficiency virus, type 1 (HIV-1), has limited the efficacy of anti-acquired immune deficiency syndrome (AIDS) treatments, and new lead compounds that target novel binding sites are needed. We have determined the 3.15 Å resolution crystal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Himmel, Daniel M., Sarafianos, Stefan G., Dharmasena, Sanjeewa, Hossain, Mohammed M., McCoy-Simandle, Kessler, Ilina, Tatiana, Clark, Arthur D., Knight, Jennifer L., Julias, John G., Clark, Patrick K., Krogh-Jespersen, Karsten, Levy, Ronald M., Hughes, Stephen H., Parniak, Michael A., Arnold, Eddy
Format: Artigo
Jezik:Inglês
Izdano: 2006
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963427/
https://ncbi.nlm.nih.gov/pubmed/17184135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb600303y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items